Lothaire Phillipe, de Azambuja Evandro, Dequanter Didier, Lalami Yassine, Sotiriou Christos, Andry Guy, Castro Gilberto, Awada Ahmad
Department of Surgery, Institut Jules Bordet, Brussels, Belgium.
Head Neck. 2006 Mar;28(3):256-69. doi: 10.1002/hed.20326.
The aim of this article is to review recent developments in the biological understanding of head and neck squamous cell carcinomas.
We describe the markers according to their function and their prognostic or predictive roles. Some associations can be found between molecular markers and invasiveness, aggressiveness, degree of differentiation, and tumor stage, but only a few clinical studies have shown an impact on prognosis. In addition, despite an increasing number of articles relating to this topic, the small number of patients included in the studies reported reduces the clinical implications of these results. Few studies applied a more comprehensive molecular analysis approach, such as DNA microarrays or differential expression profiling by polymerase chain reaction, to identify a combination of markers that could be more informative than a single molecular marker.
Some progress has been made with respect to molecular markers and head and neck cancers. Translational and prospective, hypothesis-driven research must proceed with sufficient rigor to facilitate the clinical applicability of such results.
本文旨在综述对头颈部鳞状细胞癌生物学理解的最新进展。
我们根据标志物的功能及其预后或预测作用进行描述。分子标志物与侵袭性、侵袭性、分化程度和肿瘤分期之间存在一些关联,但只有少数临床研究表明其对预后有影响。此外,尽管关于该主题的文章数量不断增加,但所报道研究纳入的患者数量较少,降低了这些结果的临床意义。很少有研究采用更全面的分子分析方法,如DNA微阵列或聚合酶链反应进行差异表达谱分析,以确定比单一分子标志物更具信息量的标志物组合。
在分子标志物与头颈部癌症方面已取得一些进展。转化性和前瞻性的、基于假设的研究必须足够严谨地进行,以促进此类结果的临床应用。